Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by IGI LABS INC
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
013055
NORFLEX
New Drug Application
Approval
New formulation
(P) Priority review drug
018656
DOPAMINE HYDROCHLORIDE
New Drug Application
Approval
019090
ZANTAC
New Drug Application
Approval
New formulation
(S) Standard review drug
019593
ZANTAC IN PLASTIC CONTAINER
New Drug Application
Approval
New formulation
(S) Standard review drug
050558
ZINACEF
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
050578
FORTAZ
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
050634
FORTAZ IN PLASTIC CONTAINER
New Drug Application
Approval
New formulation
(S) Standard review drug
050643
ZINACEF IN PLASTIC CONTAINER
New Drug Application
Approval
New formulation
(S) Standard review drug
050694
CEFOTAN IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
062928
CLINDAMYCIN PHOSPHATE
Abbreviated New Drug Application
Approval
063119
TOBRAMYCIN SULFATE
Abbreviated New Drug Application
Approval
063120
TOBRAMYCIN SULFATE
Abbreviated New Drug Application
Approval
063121
TOBRAMYCIN SULFATE
Abbreviated New Drug Application
Approval
063122
TOBRAMYCIN SULFATE
Abbreviated New Drug Application
Approval
063167
AMIKACIN SULFATE
Abbreviated New Drug Application
Approval
063169
AMIKACIN SULFATE
Abbreviated New Drug Application
Approval
070087
DOPAMINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
070089
DOPAMINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
070090
DOPAMINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
070091
DOPAMINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
070092
DOPAMINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
070093
DOPAMINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
070094
DOPAMINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
070095
FUROSEMIDE
Abbreviated New Drug Application
Approval
070096
FUROSEMIDE
Abbreviated New Drug Application
Approval
072019
DROPERIDOL
Abbreviated New Drug Application
Approval
072020
DROPERIDOL
Abbreviated New Drug Application
Approval
072021
DROPERIDOL
Abbreviated New Drug Application
Approval
072070
NALBUPHINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072071
NALBUPHINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072072
NALBUPHINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072073
NALBUPHINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072074
NALBUPHINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072075
NALBUPHINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072082
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072083
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072084
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072085
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072086
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072087
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072088
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072089
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072090
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072091
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072092
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072093
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
072210
PANCURONIUM BROMIDE
Abbreviated New Drug Application
Approval
072211
PANCURONIUM BROMIDE
Abbreviated New Drug Application
Approval
072212
PANCURONIUM BROMIDE
Abbreviated New Drug Application
Approval
072213
PANCURONIUM BROMIDE
Abbreviated New Drug Application
Approval
073690
CALCITONIN-SALMON
Abbreviated New Drug Application
Approval
075263
MIDAZOLAM HYDROCHLORIDE
Abbreviated New Drug Application
Approval
089239
MANNITOL 25%
Abbreviated New Drug Application
Approval
089240
MANNITOL 25%
Abbreviated New Drug Application
Approval
089781
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
089782
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
089783
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
089784
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
089785
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
089786
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
089787
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
089788
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
Back to Companies who have applied for FDA Drug Approval